As of the latest SEC filings, Viking Therapeutics, Inc. (VKTX) is held by 267 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $114,094,090.88 in market value, representing 0.01% of its portfolio.
Funds holding Viking Therapeutics, Inc. (VKTX)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- VKTX
- CIK:
- 0001607678
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $114,094,090.88 | 3,506,272 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.05% | $82,359,390.80 | 2,531,020 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.04% | $77,093,410.06 | 2,369,189 | Mar 31, 2026 | May 28, 2026 |
|
ATHWX
Heritage Fund
|
MF | American Century | 0.91% | $48,930,992.26 | 1,569,307 | Apr 30, 2026 | Jun 26, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.12% | $46,047,028.60 | 1,415,090 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.05% | $42,016,071.02 | 1,291,213 | Mar 31, 2026 | May 28, 2026 |
|
FAGAX
Fidelity Advisor Growth Opportunities Fund
|
MF | Fidelity | 0.12% | $35,944,103.52 | 1,062,178 | Feb 28, 2026 | Apr 24, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.33% | $20,304,000.00 | 600,000 | Feb 28, 2026 | Apr 24, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.05% | $20,021,300.64 | 591,646 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.09% | $18,571,222.80 | 548,795 | Feb 28, 2026 | Apr 24, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.22% | $14,392,964.16 | 425,324 | Feb 27, 2026 | Apr 24, 2026 |
|
FCDTX
Fidelity Stock Selector Small Cap Fund
|
MF | Fidelity | 0.20% | $14,146,366.00 | 453,700 | Apr 30, 2026 | Jun 26, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 0.74% | $14,036,830.66 | 450,187 | Apr 30, 2026 | Jun 26, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.06% | $13,847,817.50 | 444,125 | Apr 30, 2026 | Jun 26, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.26% | $13,680,056.88 | 404,257 | Feb 28, 2026 | Apr 24, 2026 |
|
IWR
iShares Russell Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.03% | $13,656,972.92 | 419,698 | Mar 31, 2026 | May 28, 2026 |
|
FSMDX
Fidelity Mid Cap Index Fund
|
MF | Fidelity | 0.03% | $12,583,749.12 | 403,584 | Apr 30, 2026 | Jun 26, 2026 |
|
DFSCX
U.S. MICRO CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.15% | $10,913,498.88 | 350,016 | Apr 30, 2026 | Jun 24, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.05% | $10,845,889.20 | 320,505 | Feb 28, 2026 | Apr 28, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.00% | $10,767,888.00 | 318,200 | Feb 28, 2026 | Apr 24, 2026 |
|
DLHAX
Nomura Healthcare Fund
|
MF | Independent / Boutique | 1.62% | $10,741,454.00 | 330,100 | Mar 31, 2026 | May 28, 2026 |
|
FSOPX
Fidelity Series Small Cap Opportunities Fund
|
MF | Fidelity | 0.19% | $9,765,607.18 | 313,201 | Apr 30, 2026 | Jun 26, 2026 |
|
WGMCX
Wasatch Ultra Growth Fund
|
MF | Independent / Boutique | 2.43% | $9,756,826.14 | 299,841 | Mar 31, 2026 | May 5, 2026 |
|
FACTX
Fidelity Advisor Health Care Fund
|
MF | Fidelity | 0.30% | $8,730,400.00 | 280,000 | Apr 30, 2026 | Jun 26, 2026 |
|
IWD
iShares Russell 1000 Value ETF
|
ETF | BlackRock / iShares | 0.01% | $7,439,001.94 | 228,611 | Mar 31, 2026 | May 22, 2026 |
Advertisement (320x50)